Literature DB >> 17974883

Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells.

D Dallari1, L Savarino, C Stagni, E Cenni, A Cenacchi, P M Fornasari, U Albisinni, E Rimondi, N Baldini, A Giunti.   

Abstract

BACKGROUND: There is great interest in the use of bone substitutes to improve bone repair. We compared the osteogenic potential of lyophilized bone chips combined with platelet gel, or with platelet gel and bone marrow stromal cells, with that of lyophilized bone chips alone in the healing of a high tibial osteotomy.
METHODS: A prospective, randomized, controlled study was performed, and a standardized clinical model was applied. Thirty-three patients undergoing high tibial osteotomy to treat genu varum were enrolled and assigned to three groups. During the osteotomy, lyophilized bone chips with platelet gel were implanted into eleven patients (Group A), lyophilized bone chips with platelet gel and bone marrow stromal cells were implanted in twelve patients (Group B), and lyophilized bone chips without gel were placed in ten patients as controls (Group C). Six weeks after surgery, computed tomography-guided biopsies of the grafted areas were performed and the specimens were analyzed by histomorphometry. Clinical and radiographic evaluation was performed at six weeks, twelve weeks, six months, and one year after surgery.
RESULTS: Histomorphometry at six weeks showed significantly increased osteoblasts and osteoid areas in both Group A (p = 0.006 and p = 0.03, respectively) and Group B (p = 0.009 and p = 0.001) in comparison with controls, as well as increased bone apposition on the chips (p = 0.007 and p = 0.001, respectively), which was greater in Group B than in Group A (p < 0.05). Group B showed significantly higher revascularization than the controls (p = 0.004). Radiographs revealed a significantly higher rate of osseointegration in Groups A and B than in the controls at six weeks (p < 0.005 and p < 0.0001, respectively). At the final evaluation at one year, the osseointegration was still better in Groups A and B than in Group C; however, all patients had complete clinical and functional evidence of healing.
CONCLUSIONS: Adding a platelet gel or a platelet gel combined with bone marrow stromal cells to lyophilized bone chips increases the osteogenetic potential of the lyophilized bone chips and may be a useful tool in the treatment of patients with massive bone loss.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17974883     DOI: 10.2106/JBJS.F.01026

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  61 in total

1.  The use of autologous blood-derived growth factors in bone regeneration.

Authors:  Roberto Civinini; Armando Macera; Lorenzo Nistri; Birgit Redl; Massimo Innocenti
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

2.  [Platelet-rich plasma combined with autologous cancellous bone : An alternative therapy for persistent non-union?].

Authors:  M Hakimi; P Jungbluth; S Thelen; M Betsch; W Linhart; S Flohé; J Windolf; M Wild
Journal:  Unfallchirurg       Date:  2011-11       Impact factor: 1.000

Review 3.  Application of stem cells in bone repair.

Authors:  Elaine Y L Waese; Rita A Kandel; Rita R Kandel; William L Stanford
Journal:  Skeletal Radiol       Date:  2008-01-12       Impact factor: 2.199

Review 4.  Background and rationale of platelet gel in orthopaedic surgery.

Authors:  Elisabetta Cenni; Lucia Savarino; Francesca Perut; Caterina Fotia; Sofia Avnet; Giacomo Sabbioni
Journal:  Musculoskelet Surg       Date:  2009-11-24

Review 5.  Results of high tibial osteotomy: review of the literature.

Authors:  Annunziato Amendola; Davide Edoardo Bonasia
Journal:  Int Orthop       Date:  2009-10-17       Impact factor: 3.075

6.  Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy.

Authors:  A Marmotti; F Castoldi; R Rossi; S Marenco; A Risso; M Ruella; A Tron; A Borrè; D Blonna; C Tarella
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-08-08       Impact factor: 4.342

Review 7.  [Cell therapy in bone-healing disorders].

Authors:  M Jäger; P Hernigou; C Zilkens; M Herten; J Fischer; R Krauspe
Journal:  Orthopade       Date:  2010-04       Impact factor: 1.087

Review 8.  Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives.

Authors:  Andre F Steinert; Lars Rackwitz; Fabian Gilbert; Ulrich Nöth; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2012-02-22       Impact factor: 6.940

Review 9.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

10.  Opening wedge high tibial osteotomy: plate position and biomechanics of the medial tibial plateau.

Authors:  Pilar Martinez de Albornoz; Manuel Leyes; Francisco Forriol; Angelo Del Buono; Nicola Maffulli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-04-30       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.